Form 4: Phreesia SVP David Linetsky Sells Shares Under 10b5-1 Plan

Phreesia's Senior Vice President, David Linetsky, sold 11,853 shares of common stock at an average price of $24.851 per share, as part of a pre-arranged trading plan.

Summary

• David Linetsky, a Senior Vice President at Phreesia, Inc., sold 11,853 shares of common stock on December 11, 2024.
• The sale was executed under a Rule 10b5-1 trading plan adopted on July 18, 2024.
• The shares were sold at a weighted average price of $24.851 per share, with individual transaction prices ranging from $24.50 to $25.38.
• Following the transaction, Mr. Linetsky directly owns 188,354 shares and indirectly owns 8,971 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive under a pre-arranged plan. It does not suggest any positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives to use 10b5-1 plans to sell shares to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the healthcare technology sector like Phreesia.
• Similar filings are regularly seen from executives at companies like Veeva Systems and athenahealth, indicating a standard approach to managing personal stock holdings.
• The reported sale price range is within the typical trading range for Phreesia stock, suggesting no unusual market activity related to this transaction.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's overall performance or valuation.

Key Dates

Keywords

Phreesia, David Linetsky, stock sale, 10b5-1 plan, insider trading, equity securities